Crohn's disease

We are inviting adults living with moderately to severely active Crohn’s Disease to take part in a research study testing an investigational medication that may help reduce inflammation and symptoms associated with Crohn’s Disease.

The study aims to evaluate the safety and effectiveness of an investigational drug in people who have not responded well to current treatments for Crohn’s Disease.

You may be able to take part if you are:

·      Aged 18–75 years.

·      Diagnosed with Crohn’s Disease at least 3 months ago.

·      Currently experiencing a flare or active symptoms (moderate to severe).

Your medical history and other aspects of your health will also be reviewed to determine if you are able to participate in the study.

Registering your interest does not require you to make an immediate decision about participation. Should you choose to join, you may withdraw from the trial at any time.

For more information and to discuss your potential eligibility please register you interest by completing the online Contact Us form or by clicking the button below.